Literature DB >> 34515584

Concurrent lacrimal gland melanocytoma and ocular melanocytosis in a dog.

Ikki Mitsui1, Seigi Nishimura2.   

Abstract

A 9-y-5-mo-old, spayed female, mixed-breed dog with buphthalmia and elevated intraocular pressure in the left eye, consistent with glaucoma, was evaluated. Black-pigmented, slightly elevated tissue with irregular margins was noted on the dorsolateral aspect of the left globe. Ultrasonography detected a mass, later identified as lacrimal gland, adjacent to the globe and the thickened uvea. The surgically removed lacrimal gland was effaced by dense sheets of melanin-laden cells. Within the enucleated globe, numerous melanin-laden cells infiltrated and expanded the rostral two-thirds thickness of the cornea, the entire anterior uvea (iris and ciliary body), and a rostral portion of the choroid. Melanin-laden cells in the left lacrimal gland and globe showed no nuclear atypia or mitotic figures, and reacted to anti-S100 and anti-melan A antibodies by immunohistochemistry. Our final diagnosis was concurrent lacrimal gland melanocytoma and ocular melanocytosis. The trabecular meshwork of the eye was obliterated by melanin-laden cells, which was the likely cause of glaucoma in this patient. To our knowledge, melanocytoma affecting the lacrimal gland has not been reported previously in a non-human mammalian species. Veterinary clinicians are encouraged to include melanocytoma in the differential list when examining an enlarged lacrimal gland.

Entities:  

Keywords:  dogs; eye; immunohistochemistry; lacrimal gland; melanocytoma; melanocytosis

Mesh:

Year:  2021        PMID: 34515584      PMCID: PMC8689046          DOI: 10.1177/10406387211045027

Source DB:  PubMed          Journal:  J Vet Diagn Invest        ISSN: 1040-6387            Impact factor:   1.569


  11 in total

1.  A pleomorphic adenoma of the lacrimal gland in a dog.

Authors:  K Hirayama; Y Kagawa; K Tsuzuki; T Kotani; Y Azuma; T Yoshino; H Taniyama
Journal:  Vet Pathol       Date:  2000-07       Impact factor: 2.221

2.  Melanoma of the lacrimal gland: a case report.

Authors:  Mallika Tewari; Sunil Choudhary; Vishwanath Sherigar; Mohan Kumar; Hari S Shukla
Journal:  J Surg Oncol       Date:  2012-06-11       Impact factor: 3.454

3.  Black tears (melanodacryorrhea) from uveal melanoma.

Authors:  Fariba Ghassemi; Carol L Shields; Melis Palamar; Ralph C Eagle; Jerry A Shields
Journal:  Arch Ophthalmol       Date:  2008-08

4.  A melanocyte--melanoma precursor niche in sweat glands of volar skin.

Authors:  Natsuko Okamoto; Takahiro Aoto; Hisashi Uhara; Satoshi Yamazaki; Hidenori Akutsu; Akihiro Umezawa; Hiromitsu Nakauchi; Yoshiki Miyachi; Toshiaki Saida; Emi K Nishimura
Journal:  Pigment Cell Melanoma Res       Date:  2014-09-04       Impact factor: 4.693

5.  Malignant melanoma of the lacrimal drainage apparatus complicating conjunctival melanoma.

Authors:  Khami Satchi; Penny McKelvie; Alan A McNab
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2015 May-Jun       Impact factor: 1.746

6.  Third eyelid gland neoplasms of dogs and cats: a retrospective histopathologic study of 145 cases.

Authors:  D Dustin Dees; Charles S Schobert; Richard R Dubielzig; Timothy J Stein
Journal:  Vet Ophthalmol       Date:  2015-04-01       Impact factor: 1.644

7.  Nevus of Ota (oculodermal melanocytosis) in a dog.

Authors:  Pedro Malho; Anita Shea; David Donaldson
Journal:  Vet Ophthalmol       Date:  2017-07-25       Impact factor: 1.644

Review 8.  An Update on Tumors of the Lacrimal Gland.

Authors:  Simon Andreasen; Bita Esmaeli; Sarah Linéa von Holstein; Lauge Hjorth Mikkelsen; Peter Kristian Rasmussen; Steffen Heegaard
Journal:  Asia Pac J Ophthalmol (Phila)       Date:  2017 Mar-Apr

9.  Oculodermal Melanocytosis: Nevus of Ota in a Dog.

Authors:  Stamatina Giannikaki; Kit Sturgess; Emma Scurrell; Prado Cebrian; Natalia Escanilla; Robert C Lowe
Journal:  Vet Pathol       Date:  2019-01-27       Impact factor: 2.221

10.  Lacrimal Sac Malignant Melanoma in 15 Japanese Patients: Case Report and Literature Review.

Authors:  Toshihiko Matsuo; Takehiro Tanaka; Osamu Yamasaki
Journal:  J Investig Med High Impact Case Rep       Date:  2019 Jan-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.